CureVac shares drop 9% on final data from phase 2b/3 trial on COVID vaccine

Register for real-time alerts, custom portfolio, and market movers

Get Started

CureVac shares drop 9% on final data from phase 2b/3 trial on COVID vaccine

To read the full story on Seeking Alpha, click here.

CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more CureVac NV Charts.

CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more CureVac NV Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

CureVac NV News

More CureVac NV News Articles

Net Savings Link (PK)

Apple Rush (PK)

Global Developments (PK)

International Star (PK)

Nexus Energy Services (PK)

Enzolytics (PK)

Rennova Health (PK)

FBEC Worldwide (PK)

GNCC Capital (CE)

Plandai Biotechnology (PK)

Delayed Upgrade Clock